Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D05JSU
|
|||
Former ID |
DNCL003069
|
|||
Drug Name |
Edivoxetine
|
|||
Synonyms |
LY2216684
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Major depressive disorder [ICD-11: 6A70.3; ICD-10: F32.2] | Phase 3 | [1] | |
Pediatric attention deficit hyperactivity disorder [ICD-11: 6A05] | Phase 3 | [1] | ||
Company |
Eli Lilly
|
|||
Structure |
Download2D MOL |
|||
Formula |
C18H26FNO4
|
|||
Canonical SMILES |
COC1=C(C=C(C=C1)F)CC(C2CCOCC2)(C3CNCCO3)O
|
|||
InChI |
1S/C18H26FNO4/c1-22-16-3-2-15(19)10-13(16)11-18(21,14-4-7-23-8-5-14)17-12-20-6-9-24-17/h2-3,10,14,17,20-21H,4-9,11-12H2,1H3/t17-,18+/m0/s1
|
|||
InChIKey |
CPBHSHYQQLFAPW-ZWKOTPCHSA-N
|
|||
CAS Number |
CAS 1194508-25-2
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT01370499) A Study of LY2216684 in Patients With Major Depression Disorder. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.